BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.580
0.00 (0.00%)
May 9, 2025, 10:55 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
Neuroscience and Immuno-oncology Drugs
1.38M
Log In
Neuroscience and Immuno-oncology Drugs Growth
268.00%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
United States
1.38M
Log In
United States Growth
268.00%
Log In